Background The role of ERG‐status molecular subtyping in prognosis of prostate cancer
(PCa) is still under debate. In this study, we identified differentially expressed genes (DEGs) …

INTRODUCTION Page 1 New Molecular Markers for Prostate Cancer Diagnosis Mahan Amiri1,
Leila Asadi Samani1, Amir Hossein Kashi2, Nazanin Khadem3, Seyed Amir Mohsen Ziaee2 …

Recent observations of novel long non-coding RNAs (lncRNAs) have considerably altered
our understanding of cell biology. The role of lncRNAs as tumor suppressors or oncogenes …

A major racial disparity in prostate cancer (PCa) is that African American (AA) patients have
a higher mortality rate than European American (EA) patients. We filtered the SEER 2009 …

The TMPRSS2: ERG gene fusion is the most prevalent early driver gene activation in
prostate cancers of European ancestry, while the fusion frequency is much lower in Africans …

Prostate cancer remains a major public health problem and the second leading cause of
cancer-related deaths in men in the United States. The present study aims to understand the …

Management of patients with prostate cancer is currently based on imperfect clinical,
biological, radiological and pathological evaluation. Prostate cancer aggressiveness …

Purpose Prostate cancer is the second most common malignancy among men worldwide,
and it poses a significant public health burden that has traditionally been limited mostly to …

Given the known association of gene fusions with solid tumor morbidity and the need to
clarify the role of fusions in therapeutic, prognostic and diagnostic outcomes, we reviewed …

Background With the advances in next-generation sequencing technologies, it is possible to
determine RNA-RNA interaction and RNA structure predictions on a genome-wide level …